Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.

Hamaguchi, Tetsuya

Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer. [electronic resource] - Cancer science Nov 2019 - 3565-3572 p. digital

Publication Type: Journal Article; Multicenter Study

1349-7006

10.1111/cas.14198 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Asian People
Biomarkers, Tumor--blood
Camptothecin--analogs & derivatives
Colonic Neoplasms--blood
Fluorouracil--therapeutic use
Humans
Insulin-Like Growth Factor Binding Protein 1--blood
Interleukin-8--blood
Japan
Kallikreins--blood
Leucovorin--therapeutic use
Placenta Growth Factor--blood
Prognosis
Progression-Free Survival
Prospective Studies
Pulmonary Surfactant-Associated Protein D--blood
Receptor for Advanced Glycation End Products--blood
Receptors, Tumor Necrosis Factor, Type II--blood
Receptors, Vascular Endothelial Growth Factor--therapeutic use
Recombinant Fusion Proteins--therapeutic use
Rectal Neoplasms--blood
Regression Analysis
Tenascin--blood
Tissue Inhibitor of Metalloproteinase-1--blood
Vascular Endothelial Growth Factor Receptor-1--blood